心理护理对性病患者治疗效果影响的分析

目的：探讨性病患者在临床治疗期间开展心理护理的临床效果.方法：选取2010年3月至2013年3月来我院性病门诊就诊的126例患者,随机分为实验组和对照组各63例.对照租常规治疗,实验组在常规治疗基础上加入心理护理治疗.结果：实验组住院天数明显少于对照组,差异有统计学意义（P＜0.05）;临床治愈率,对照组为66.67%,实验组为93.65%,两组比较差异有统计学意义（P＜0.05）.结论：对于性病患者正规治疗的同时,辅以心理治疗,可明显提高治愈率.     

阿维A治疗寻常性银屑病疗效与药物遗传学相关性研究

目的探讨阿维A治疗寻常性银屑病疗效与药物遗传学的相关性。方法运用PCR、电泳、测序等方法检测寻常性银屑病患者的基因单核苷酸多态性,同时观察阿维A治疗寻常性银屑病的临床疗效。结果 100例寻常性银屑病患者中rs833061C/C型10例(10%),rs833061T/T型46例(46%),rs833061C/T型44例(44%),rs2010963G/G型51例(51%),rs2010963C/G型33例(33%),rs2010963C/C型16例(16%)。rs833061C/T型患者采用阿维A治疗的有效率为90.9%,高于其他各型,差异有统计学意义(P<0.05)。其他各型之间的治愈率和有效率相比差异无统计学意义(P>0.05)。结论阿维A治疗寻常性银屑病,其基因型为rs833061C/T的患者治疗效果好。     

心理治疗在伴性功能障碍的ⅢB型慢性前列腺炎患者中作用的临床研究

目的：探讨心理治疗在伴性功能障碍的ⅢB型慢性前列腺炎患者中的作用。方法：对328例ⅢB型慢性前列腺炎伴性功能障碍患者进行随机对照研究。对照组164例给予常规的药物治疗,治疗组164例在常规药物治疗基础上,同时给予心理治疗。结果：两组患者性功能障碍在治疗后均有明显改善,治疗组患者早泄及勃起功能障碍的有效例数和治愈率均明显优于对照组（P〈0.01）。结论：在常规药物治疗的基础上辅以心理治疗对伴性功能障碍的ⅢB型慢性前列腺炎是有效的,值得临床推广。     

尖锐湿疣皮损中高危型和低危型人乳头瘤病毒感染情况研究

目的:研究尖锐湿疣皮损中高危型和低危型人乳头瘤病毒(Human papillomavirus,HPV)感染情况。方法:研究纳入235例人乳头瘤病毒检查结果阳性的患者,对其型别、各型感染率及病毒拷贝数进行统计分析。结果:235例人乳头瘤病毒感染阳性患者,存在348人次人乳头瘤病毒感染,统计结果如下:HPV6和HPV11(36.7%,128/348)、HPV16(7.5%,26/348)、HPVl8(3.5%,12/348)、HPV31(1.7%,6/348)、HPV33(2.9%,10/348)、HPV35(2%,7/348)、HPV39(5.2%,18/348)、HPV45(1.1%,4/348)、HPV51(5.7%,20/348)、HPV52(11.5%,40/348)、HPV56(2.9%,10/348)、HPV58(10.1%,35/348)、HPV59(5.5%,,19/348)、HPV68(3.7%,13/348)。235例患者中128例为尖锐湿疣低危型HPV6及HPV11感染,高危型HPV中HPV52感染率最高,其次为HPV58,然后依次为HPV16,HPV51,HPV59,HPV39,HPV68,HPV18,HPV33,HPV56,HPV33,HPV31,感染率最低的是HPV45。感染低危型HPV6及HPV11患者为128例,只感染低危型HPV6及HPV11的患者为82例;感染高危型HPV患者为153例,只感染高危型HPV的患者为107例。低危型和高危型混合感染患者为46例。HPV感染拷贝数主要集中在107-103/104细胞。结论:尖锐湿疣中HPV6和11阳性率最高,高危型HPV可以和低位型HPV合并感染,也可以单独感染,发病率呈增高趋势,因此需要加强尖锐湿疣患者的治疗至关重要。     

慢性前列腺炎的心理治疗（附62例报告）

目的观察并探讨慢性前列腺炎的心理治疗问题.方法62例确诊的慢性前列腺炎病人随机分两组,每组31例.对照组采用临床常规方法进行治疗,治疗组在接受常规治疗的同时辅以心理治疗.结果经1～2疗程治疗并随访2个月后,按照统一制定的疗效评定标准对两组病人疗效进行评分,再对疗效分布情况进行比较,治疗组总有效率100%(31/31),对照组总有效率90.32%(28/31),两组治疗效果分布有显著性差异(P＜0.05).结论对慢性前列腺炎疾患在进行常规治疗的同时应辅以积极的心理治疗.心理治疗应该被看做是整个治疗的一个重要组成部分.     

复方甘草酸苷片联合NB-UVB治疗老年性皮肤瘙痒症疗效观察

目的观察复方甘草酸苷片联合NB-UVB治疗老年性皮肤瘙痒症的疗效。方法 56例老年性皮肤瘙痒症患者随机分为两组,治疗组29例采用复方甘草酸苷片联合NB-UVB照射治疗;对照组27例仅NB-UVB照射治疗;两组均每晚口服扑尔敏片4mg,并辅以身心健康教育,3周后观察疗效。结果治疗组有效率96.55%,对照组为70.37%,两组差异有统计学意义(P<0.05)。结论复方甘草酸苷片联合NB-UVB治疗老年性皮肤瘙痒症疗效较好。     

心理因素与皮肤疾病

许多研究表明心理因素与皮肤病之间关系密切。文中探讨了心理因素在皮肤病发生、发展及转归中的作用机制,提出在对皮肤病患者进行常规治疗的同时辅以心理治疗及护理有利于巩固治疗效果,提高患者的生活质量。     

中药合剂联合心理疗法治疗ⅢB型慢性前列腺炎疗效观察

目的:探讨中药合剂联合心理疗法治疗ⅢB型慢性前列腺炎的临床疗效。方法:选择确诊的ⅢB型慢性前列腺炎患者180例进行随机对照研究。对照组90例给予中药合剂治疗,治疗组90例给予中药合剂联合心理治疗。比较两组的治疗效果,对生存质量评分和采用焦虑自评量表(SAS)评定病人焦虑状态的改善情况。结果:对照组有效率为77.8%,治疗组有效率为93.3%,两组有效率比较,差异有统计学意义(P<0.05);治疗组患者生活质量各维度得分显著高于对照组(P<0.05);两组患者的焦虑自评量表评分与治疗前相比,均显著下降(P<0.05);治疗后,治疗组的SAS评分显著低于对照组(P<0.05);两组患者在治疗过程中均未出现与治疗药物有关的不良反应。结论:中药合剂联合心理治疗在ⅢB型慢性前列腺炎患者对ⅢB型慢性前列腺炎疗效显著,可减轻患者的焦虑情绪,提高患者的生存质量,无不良反应,值得临床推广。     

心理治疗联合盐酸舍曲林治疗早泄效果及对患者性生活满意度的影响

目的:探讨心理治疗联合盐酸舍曲林治疗早泄效果及对患者性生活满意度的影响。方法:选取2015年1月至2016年1月间于我院泌尿科治疗的早泄患者80例作为研究对象,随机分为观察组和对照组,对照组患者接受盐酸舍曲林药物治疗方式,而观察组在此基础上辅以小组心理干预,治疗周期结束后,比较两组患者的早泄症状改善情况以及CIPE-5、CIPE-7满意程度评分。结果:治疗周期结束后,观察组患者早泄轻度、中度、重度程度分布分别由治疗前的13例、17例、10例分别改善为35例、5例、0例,其改善程度明显优于对照组(P0.05),而性满意程度评分也有治疗前的(3.21±0.51)分、(2.79±0.43)分提高为(4.21±0.78)分、(3.88±0.64)分,明显优于对照组(P0.05)。结论:心理治疗联合盐酸舍曲林治疗早泄临床效果较优,可以明显提高患者以及配偶性满意度,可以适当临床推广。     

保守手术联合戈舍瑞林治疗子宫内膜异位症临床疗效及受孕状况研究

目的:探讨保守手术联合戈舍瑞林治疗子宫内膜异位症(EMT)患者临床疗效,并观察其受孕状况,为临床治疗提供依据。方法:选择我院2012年1月至2013年6月收治的EMT妇女104例,根据治疗方法将所有患者分为对照组和治疗组,对照组51例,给予腹腔镜保守手术治疗;观察组53例,在对照组基础上应用戈舍瑞林治疗。主要观察指标为治疗效果、术后6个月和1年血清促黄体生成素(LH)、促卵泡激素(FSH)和雌二醇(E2)含量;并观察治疗后妊娠率。结果:观察组有效率为37.74%(20/53),高于对照组25.49%(13/51),差异有统计学意义(P0.05);观察组无效率为3.77%(2/53),低于对照组17.65%(9/51),差异有统计学意义(P0.05);观察组患者妊娠率为39.62%(21/53),高于对照组19.61%(10/51),差异有统计学意义(P0.05);观察组患者治疗6个月和1年LH和FSH分别为(36.27±2.02)U/L、(35.37±3.61)U/L和(43.08±2.86)U/L、(42.16±3.07)U/L,均高于对照组,差异具有统计学意义(P0.05);观察组治疗六个月和一年E2为(51.67±2.69)pmol/L、(42.55±3.92)pmol/L,低于对照组,差异具有统计学意义(P0.05)。结论:保守手术联合戈舍瑞林明显提高EMT临床效果,提高患者妊娠率。     

性传播疾病患者的心理治疗及护理

目的:探讨心理治疗在性传播疾病患者治疗中的作用.方法:医患之间建立良好的相互信任和依赖关系,针对不同的心理状态施以适当的心理疏导,将躯体性治疗和心理治疗有机地结合起来.结果:在临床工作中取得显著的效果.结论:要重视性传播疾病患者的心理表现,针对不同的心理状态施以适当的心理疏导,将躯体性治疗和心理治疗有机地结合起来,有利于患者早日康复.     

Personality dimensions of sexually transmitted disease repeaters assessed with the Millon Clinical Multiaxial Inventory

OBJECTIVE: To assess the personality characteristics of patients with repeated sexually transmitted diseases (STD). METHOD: A case-control study comparing 101 STD repeaters (subjects with a lifetime history of three or more STDs) with 182 controls who had no history of STD. All subjects attended the City Department for Skin and Venereal Diseases in Belgrade (Yugoslavia) from June 1997 to April 1998. Personality characteristics was assessed by the Millon Clinical Multiaxial Inventory (MCMI). RESULTS: The analysis of MCMI test showed that STD repeaters had higher scores on narcissistic, antisocial and paranoid scales. The difference between STD repeaters and the controls was significant on antisocial, psychotic thinking and psychotic delusion scales, although scores on clinical syndromes were low for both cases and controls. Discriminant analysis showed that antisocial personality was predictive for STD repeaters. CONCLUSIONS: This study support the hypothesis that STD repeaters are different from controls in terms of their psychological characteristics. The behaviour of STD repeaters is ego-syntonic, which makes the treatment of their personality difficult and emphasizes the importance of work on primary and secondary prevention of STD.     

性病患者心理状态及其相关因素分析

目的：调查性病患者焦虑抑郁情绪的发生率及相关因素，方法：采用Zung抑郁自评量表，焦虑自评量表及相关因素问卷进行测评及相关分析，结果：性病患者焦虑、抑郁情绪的发生率分别为66．7％及65．0％，其发生与患者的病程，疾病的各类，初次就诊情况，性病知识来源，治疗情况及躯体症状密切相关，结论：性病患者存在严重的心理问题，规范治疗同时给予心理干预则有助于性病患者的康复。     

性病患者心理健康状况调查分析

目的：调查性病患者心理健康状况。方法：对64例性病患者进行Zung氏焦虑、忧郁自评表2睡眠状况问卷测试。结果：发现9．38％的病人出现焦虑症状，31．25％的病人出现抑郁症状，96．88％的病人有不同程度的睡眠障碍。结论：在治疗性病的同时，应重视性病患者的心理治疗，必要时可加用抗忧郁药。     

解郁安神汤治疗性病恐惧症致功能性阳痿32例

目的:自拟解郁安神汤治疗性病恐惧症致功能性阳痿疗效。方法:对32例性病恐惧症患者导致的功能性阳痿,用自拟解郁安神辨证加减,配合心理疗法,15天1疗程服药1-3疗程观察疗效。结果:32例患者痊愈19例,有效9例,无效4例,治愈率为59%,总有效率87.5%。讨论:性病恐惧症属自身强迫性神经官能症,是某些患者患性病治愈后或未患性病所产生不必要而且无法自制的恐惧心理,而导致的阳痿。用自拟解郁安神汤共奏疏肝解郁、养血柔肝、镇惊安神、通络兴阳之功辨证加减,配合心理疗法,使患者从恐惧中得到解脱,患者的病情得到不同程度的缓解,故对此病的治疗收到良好效果。     

性病恐惧症42例报告

目的:分析性传播疾病恐惧症的形成原因及其病例特征,探讨性传播疾病恐惧症的诊断与治疗。方法:对42例性传播疾病恐惧症患者的各种临床特征进行统计分析,并进行文献复习。结果:性传播疾病恐惧症的临床症状以生殖器官的各种不适与异常为主,发病率与不洁性生活史、性传播疾病史、文化程度、职业、思想素质、道德观念、医学误导等有关。治疗效果尚欠满意。结论:性传播疾病恐惧症原因复杂,需要严谨诊断,在治疗原发病的基础上配合解释与暗示治疗。     

Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities

BACKGROUND: Many women with positive screening tests for chlamydia or gonorrhea are not promptly treated and are at risk for complications and further disease transmission. Improved methods for notifying infected patients might increase timely treatment in this population. GOAL: Describe notification procedures at STD clinics in Washington, DC; Los Angeles; and San Diego and compare timeliness of treatment during 2000 to 2002. STUDY: Interviews were conducted to determine methods for notifying infected patients. Data were abstracted from 327 medical records of women with chlamydia or gonorrhea who had not been treated presumptively. The interval between specimen collection and treatment ("time to treatment") was calculated. RESULTS: Each clinic had different procedures for notifying untreated infected women. Among those treated, the median time to treatment was 18 days in Washington, DC, and 8 days in Los Angeles. In San Diego, the median time to treatment was initially 14 days, which improved to 7 days after patient-notification procedures were changed. CONCLUSION: Simple changes in patient notification procedures can decrease time to treatment at STD clinics. STD programs should evaluate time to treatment and institute methods for efficient patient follow-up.     

Tetracycline treatment does not eradicate Mycoplasma genitalium

OBJECTIVES: To study the treatment efficacy of tetracyclines and azithromycin in Mycoplasma genitalium positive patients attending an STD clinic. METHODS: All M genitalium positive patients (34 men and 26 women) attending an STD clinic during a 6 month period were treated with antibiotics. All patients known to be partners of M genitalium positive patients and those who were M genitalium positive, but not initially treated, were treated with azithromycin. Patients with urethritis and/or cervicitis were treated with tetracyclines before their M genitalium status was known. RESULTS: 10 of 14 women (71%) and 10 of 16 men (63%) treated with tetracyclines were M genitalium positive at follow up, whereas all patients treated with azithromycin (16 men and 20 women) were M genitalium negative, at the 4 week follow up visit. CONCLUSIONS: These results suggest that tetracyclines are not sufficient to eradicate M genitalium. Randomised controlled treatment trials are urgently needed.     

Is syndromic management better than the current approach for treatment of STDs in China? Evaluation of the cost-effectiveness of syndromic management for male STD patients

BACKGROUND: The syndromic treatment approach has not been evaluated in sexually transmitted disease (STD) clinics in China. GOAL: The goal was to evaluate and compare the validity and cost-effectiveness of syndromic management with current STD management for men in clinics in Hefei, China. STUDY DESIGN: Diagnostic accuracy, treatment appropriateness, costs, and effectiveness of current clinical procedures and syndromic management were compared for 406 men attending four STD clinics. RESULTS: A modified World Health Organization (WHO) syndromic algorithm for urethral discharge yielded 100% sensitivity and a 69% positive predictive value (PPV). A syndromic algorithm for genital ulcers correctly treated all syphilis patients, with a 25% PPV. The average cost (in US dollars) per correct treatment by the current approach was 323.48 dollars for urethritis and 85.65 dollars for syphilis. For the syndromic approach, the average cost per correct treatment was 3.15 dollars for urethritis and 13.54 dollars for syphilis. CONCLUSION: Syndromic management can provide better treatment for men with STDs at significantly lower cost in resource-poor settings such as China.